Analysts Adjust Walmart Estimates: Mixed Responses To Q3 Results with Focus On Sales Growth & Expense Concerns
Several analysts revised the price target and estimates of Walmart Inc (NYSE: WMT)
Large-Cap Stocks Pause, Small Caps Shine, Oil Makes Comeback: What’s Driving Markets Friday?
Wall Street experienced a relatively quiet session as the week came to a close, with the three major averages hovering around parity in midday trading in New York, yet still on course for their third successive week of gains.
What’s Going On With Penny Stock AgeX Therapeutics?
Serina Therapeutics Inc, a privately held, clinical-stage biotechnology company, entered into a License Agreement under which Pfizer Inc (NYSE: PFE) will license, on a non-exclusive basis, Serina's
Agricultural Science Company FMC’s Investor Day: Plans Non-Core Asset Sale, R&D Pipeline & Others
On Investor Day yesterday, FMC Corp (NYSE: FMC) disclosed its new
US Energy Company AES Eyes Sale Of Coal-Fired Power Plant In Vietnam: Report
The AES Corp (NYSE: AES) is reportedly negotiating to sell its majority interest in one of the largest coal-fired power plants in Vietnam.
The move is a part of the company's global strategy to divest coal assets by the end of 2025, as per Reuters.
Johnson & Johnson Resolves 2 Major Talc Cases As Legal Battles Continue
Johnson & Johnson (NYSE: JNJ) announced settlements in two talc-related cases, the news follows an appeals court's ruling which overturned a $223.8 million verdict
FDA Approves Merck’s Blockbuster Cancer Drug For Type Of Gastric Cancer
The FDA has approved Merck & Co Inc's (NYSE: MRK) Keytruda, an anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing chemotherapy, for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)
FDA Approves AstraZeneca’s Truqap/Faslodex Combo Therapy For Breast Cancer, Competes With Gilead’s Drug
FDA approves AstraZeneca Plc's (NASDAQ: AZN) Truqap (capivasertib) in combination with Faslodex (fulvestrant) for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or
Why Chinese Express Delivery Company ZTO Shares Are Down Today
ZTO Express (Cayman) Inc (NYSE: ZTO) shares are trading lower by around 6% after it
Defense Company Northrop Grumman Aims To Expand Production Capacity In Poland: Report
Northrop Grumman Corp (NYSE: NOC) is reportedly exploring the production of 120-millimeter tank ammunition in Poland to boost defense production capacity.